key: cord-0946875-d6fp2ibe
authors: Ruiz, J.
title: Enhanced antibiotic resistance as a collateral COVID-19 pandemic effect?
date: 2020-11-17
journal: J Hosp Infect
DOI: 10.1016/j.jhin.2020.11.010
sha: 8f86d23408949dd65e6272938dc48ed5c6cb70da
doc_id: 946875
cord_uid: d6fp2ibe

nan

Antibiotic resistance selection/development is a multifactorial phenomenon in which all factors converge 28 in a common trend: selective antibiotic pressure over microorganisms [2] . Antibiotics kill susceptible 29 bacteria, so that bacteria possessing or acquiring genes that confer resistance to those antibiotics are 30 selected in a Darwinian manner. Furthermore, while often not considered, non-antibiotic agents, such as 31 biocides or toxic substances, can also contribute to this pressure by favoring the selection/development of 

Medicación prehospitalaria en pacientes hospitalizados por 93 COVID-19 en un hospital público de Lima-Perú

Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients 97 admitted to ICU

Antimicrobial resistance: Tackling a crisis 99 for the health and wealth of nations. HM Government/Wellcome Trust